Skip to main content

Table 1 Summary of AAM originating from outside the pelvi-perineal region

From: Aggressive angiomyxoma of the liver: a case report and literature review

Author (reference) Year Location Age Sex Size (cm) Immunohistochemical exam Surgical treatment Resection margin (mm) Adjuvant therapy Disease-free survival (months) Recurrence
Magalhaes F.TD [2] 1995 Larynx 63 F 2.0 • Negative: S-100 Tumorectomy Unknown No 1 Local recurrence
Yamashita Y [3] 2004 Oral floor 8 F 2.0 • Positive: vimentin
• Negative: S-100, CD34
Surgical excision 10 No 24 None
Pai CY [4] 2008 Supraclavicular fossa 48 M 12 × 10 • Positive: vimentin, desmin, muscle-specific actin, ER
• Negative: cytokeratin, S100, PgR
Wide excision after preoperative biopsy Unknown No 6 None
Choi YD [5] 2008 Lung 70 F 6.0 × 5.5 • Positive: vimentin, desmin, actin, ER, PgR
• Negative: cytokeratin, S-100, CD34, bcl-2
Thoracoscopic surgery after preoperative needle biopsy Unknown No 8 None
Sylvester DC [6] 2010 Larynx 47 M 4.0 × 2.5 • Negative: S-100, desmin, CD34, SMA Laryngofissure approach excision biopsy and covering tracheostomy Unknown No 48 None
Qi S [7] 2015 Liver 50 F 2.0 × 2.0 • Positive: vimentin, CD34, SMA
• Negative: desmin, S-100, Ki-67, EMA, ER, PgR, CD99, CD10, CAM5.2, CK19
Partial hepatectomy Unknown No 6 None
Present case 2016 Liver 33 F 8.0 × 7.5 • Positive: vimentin, desmin, CD34, ER, PgR
• Negative: S-100, EMA, CD99, HMB45, CK19
Subsegmentectomy 2 No 10 None
  1. Abbreviations: AAM aggressive angiomyxoma, ER estrogen receptor, F female, M male, PgR progesterone receptor